Cargando…
From vesicle to cytosol
Drugs called bisphosphonates are used to treat a range of bone diseases, but how do they reach the enzymes that are their target?
Autores principales: | Rogers, Michael J, Munoz, Marcia A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
eLife Sciences Publications, Ltd
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6021168/ https://www.ncbi.nlm.nih.gov/pubmed/29947329 http://dx.doi.org/10.7554/eLife.38847 |
Ejemplares similares
-
Identification of a transporter complex responsible for the cytosolic entry of nitrogen-containing bisphosphonates
por: Yu, Zhou, et al.
Publicado: (2018) -
Mitochondria supply ATP to the ER through a mechanism antagonized by cytosolic Ca(2+)
por: Yong, Jing, et al.
Publicado: (2019) -
Cytosolic aggregation of mitochondrial proteins disrupts cellular homeostasis by stimulating the aggregation of other proteins
por: Nowicka, Urszula, et al.
Publicado: (2021) -
Cytosolic aspartate aminotransferase moonlights as a ribosome-binding modulator of Gcn2 activity during oxidative stress
por: Crawford, Robert A, et al.
Publicado: (2022) -
Proteomic mapping of cytosol-facing outer mitochondrial and ER membranes in living human cells by proximity biotinylation
por: Hung, Victoria, et al.
Publicado: (2017)